Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells-Reference-Cited by-同舟云学术

Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells

Published:2017-11-13 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Lindgren Gustaf,Ols Sebastian,Liang Frank,Thompson Elizabeth A.,Lin Ang,Hellgren Fredrika,Bahl Kapil,John Shinu,Yuzhakov Olga,Hassett Kimberly J.,Brito Luis A.,Salter Hugh,Ciaramella Giuseppe,Loré Karin

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination;Pardi;Nature,2017

2. Modified mRNA vaccines protect against Zika virus infection;Richner;Cell,2017

3. Recent innovations in mRNA vaccines;Ulmer;Curr Opin Immunol,2016

4. Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection;Petsch;Nat Biotechnol,2012

5. Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses;Bahl;Mol Ther,2017

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing mRNA Therapeutics: The Role and Future of Nanoparticle Delivery Systems;Molecular Pharmaceutics;2024-07-02

2. Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice;npj Vaccines;2024-06-10

3. COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children;npj Vaccines;2024-04-05

4. Influenza a Neuraminidase-Based Bivalent mRNA Vaccine Induces Th1-Type Immune Response and Provides Protective Effects in Mice;Vaccines;2024-03-13

5. mRNA-based therapeutics: looking beyond COVID-19 vaccines;The Lancet;2024-03